Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.470
-0.040 (-1.14%)
Feb 21, 2025, 4:00 PM EST - Market closed
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $10.41 million as of February 21, 2025. Its market cap has increased by 82.68% in one year.
Market Cap
10.41M
Enterprise Value
-18.55M
1-Year Change
82.68%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $10.41M, a decrease of -73.23%. That is a compound annual growth rate of -12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |